No significant differences were found between the two patient groups for a number of parameters that can influence the OS, including the age at diagnosis, WHO classification, histopathology, MGMT methylation status, idh mutation rate, and preoperative tumor volume. This evidence concerns the gene MGMT and neoplasm.